Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer

Breast cancer is the second most common cancer among women in the United States in which the standard of care treatment is surgery with adjunctive therapy. Cryoablation, which destroys the tumor using extremely cold temperatures while preserving the potential tumor antigens, is a promising alternati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sardela de Miranda, Flávia, Castro, Maribel, Remmert, Nicole, Singh, Sharda P., Layeequr Rahman, Rakhshanda, Melkus, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582696/
https://www.ncbi.nlm.nih.gov/pubmed/37860001
http://dx.doi.org/10.3389/fimmu.2023.1258873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582696/
https://www.ncbi.nlm.nih.gov/pubmed/37860001
http://dx.doi.org/10.3389/fimmu.2023.1258873

Ejemplares similares